China Grants First mRNA COVID Vaccine Approval To Homegrown Latecomer

CSPC Pharmaceutical's SYS6006 has gained an emergency use authorization in China less than one year after entering clinical trials, becoming the first mRNA vaccine for COVID-19 to be approved in the country.

China vaccines
China finally gives nod to an mRNA vaccine for COVID-19 following approvals of inactivated, adenovirus and recombinant shots • Source: Shutterstock

More from China

More from Asia